Episodes (Page 5)
✨
SGLT2 inhibitors like empagliflozin reduce urinary uromodulin without tubular injury.
Greco Malijan
✨
Low-voltage zone ablation improves rhythm outcomes in persistent AF patients.
Astrid Paul-Nordin
✨
General clinicians can identify glomerular disease earlier.
✨
Mavacamten shows sustained improvements in obstructive HCM symptoms up to 5 years.
Anjali Owens
✨
New ASN Compendium aims to unify fragmented glomerular disease care.
✨
Masking in high-dose psilocybin trials is ineffective, with >90% participant awareness.
✨
Ameluz PDT offers a nonsurgical option for select skin cancer patients.
✨
FDA approves Ameluz PDT for superficial basal cell carcinoma.
✨
Immediate coronary angiography does not improve survival after cardiac arrest without STEMI.
✨
Taladegib improves lung fibrosis markers in idiopathic pulmonary fibrosis (IPF).
✨
FIND-CKD trial excluded recent immunosuppression, but combination therapy may still work.
Brendan Neuen
✨
Finerenone's efficacy and safety in heart failure are unaffected by cardio-kidney-metabolic conditions.
John Ostrominski
✨
Nerandomilast shows durable safety and efficacy in IPF and PPF in FIBRONEER-ON.